CorFlow Therapeutics is a clinical-stage medical device company focused on transforming the diagnosis and treatment of microvascular obstruction (MVO) in heart attack patients
CorFlow Therapeutics is a clinical-stage medical device company focused on transforming the diagnosis and treatment of microvascular obstruction (MVO) in heart attack patients. The company has developed the Controlled Flow Infusion (CoFI) System, designed to diagnose MVO in real-time during percutaneous coronary intervention (PCI) and enable localized delivery of therapeutic agents directly to the microvasculature.